JCR Pharmaceuticals Co.,Ltd

4552・Prime Market・Pharmaceuticals

Official website

JCR Pharmaceuticals Co.,Ltd

4552・Prime Market・Pharmaceuticals

Official website

JCR Pharmaceuticals Co.,Ltd4552

Reference Indicators

Market Cap

678¥100M

P/E (Forecast)

318.9x

P/B

1.4x

Dividend Yield (Forecast)

3.82%

ROE

4.6%

EV/EBITDA

34.6x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	51,082	34,343	42,871	33,072	40,319
Cost of Sales	10,461	8,886	11,620	10,902	10,134
Gross Profit	40,620	25,456	31,251	22,169	30,185
SG&A Expenses	20,686	20,480	23,719	28,389	29,629
Operating Income	19,933	4,975	7,531	-6,219	555
Non-operating Income	656	541	1,056	260	1,449
Non-operating Expenses	77	99	1,324	1,088	839
Ordinary Income	20,512	5,418	7,264	-7,046	1,165
Extraordinary Income	0	10	0	1,065	2,091
Extraordinary Losses	1,108	16	20	2	32
Pre-tax Income	19,404	5,412	7,244	-5,983	3,224
Income Taxes	4,886	1,625	1,707	-1,586	1,017
Net Income	14,507	3,772	5,507	-4,460	2,178
EBITDA	21,878	6,972	10,728	-2,845	3,112
Gross Margin	79.5%	74.1%	72.9%	67.0%	74.9%
Operating Margin	39.0%	14.5%	17.6%	-18.8%	1.4%
ROA	14.9%	4.0%	5.4%	-4.3%	2.0%
ROE	32.9%	7.4%	10.3%	-8.7%	4.6%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	0	0	0.0%